Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH)

被引：0
|
作者：
Z. Wang
Z. Zhao
Y. Xia
Z. Cai
C. Wang
Y. Shen
R. Liu
H. Qin
J. Jia
G. Yuan
机构：
[1] Affiliated Hospital of Jiangsu University,Department of Endocrinology
来源：
Journal of Endocrinological Investigation | 2022年 / 45卷
关键词：
WGCNA; Single-cell RNA-seq; NASH; Fibrosis; HCC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1379 / 1392
页数：13
相关论文
共 50 条
  • [31] Disease Recurrence and Fibrosis Progression in Patients Transplanted for Nonalcoholic Steatohepatitis
    Bhati, Chandra
    Rivera, Maria
    Idowu, Michael O.
    Driscoll, Carloyn
    Kohli, Divyanshoo R.
    Stravitz, R. Todd
    Sanyal, Arun J.
    Gilles, HoChong
    Matherly, Scott C.
    Puri, Puneet
    Luketic, Velimir A.
    Lee, Hannah
    Sterling, Richard K.
    Siddiqui, Mohammad
    HEPATOLOGY, 2016, 64 : 508A - 508A
  • [32] ASSESSING THE USE OF NONINVASIVE BIOMARKERS IN DRUG DEVELOPMENT FOR NONCIRRHOTIC NONALCOHOLIC STEATOHEPATITIS (NASH).
    Tian, X.
    Li, S.
    Kim, I.
    Saluja, B.
    Doddapaneni, S.
    Sahajwalla, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S30 - S30
  • [33] Characterization of insulin resistance in patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH)
    Ratziu, Vlad
    Sanyal, Arun J.
    Loomba, Rohit
    Caldwell, Stephen H.
    Ghalib, Reem H.
    Torres, Dawn M.
    McCullough, Arthur J.
    Muir, Andrew J.
    Myers, Robert P.
    Schall, Raul E. Aguilar
    Subramanian, Mani
    McHutchison, John G.
    Bosch, Jaime
    Harrison, Stephen A.
    Abdelmalek, Manal F.
    HEPATOLOGY, 2015, 62 : 1298A - 1299A
  • [34] HIGH LEVELS OF TROPONIN I ARE ASSOCIATED WITH LIVER FIBROSIS IN NONALCOHOLIC STEATOHEPATITIS (NASH)
    Gerber, Lynn
    Karrar, Azza
    Birerdinc, Aybike
    Tran, Henry A.
    Elsheikh, Elzafir
    Paik, James
    Felix, Sean
    Jeffers, Thomas
    Younoszai, Zahra
    Racila, Andrei
    Lam, Brian P.
    Goodman, Zachary D.
    Younossi, Zobair M.
    HEPATOLOGY, 2019, 70 : 1125A - 1125A
  • [35] The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression
    Li, Xinzhi
    Yuan, Bingchuan
    Lu, Min
    Wang, Yuqin
    Ding, Na
    Liu, Chunhong
    Gao, Ming
    Yao, Zhicheng
    Zhang, Shiyan
    Zhao, Yujun
    Xie, Liwei
    Chen, Zheng
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [36] The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression
    Xinzhi Li
    Bingchuan Yuan
    Min Lu
    Yuqin Wang
    Na Ding
    Chunhong Liu
    Ming Gao
    Zhicheng Yao
    Shiyan Zhang
    Yujun Zhao
    Liwei Xie
    Zheng Chen
    Nature Communications, 12
  • [37] Osr1 DELETION IN THE MACROPHAGES PROMOTED NONALCOHOLIC STEATOHEPATITIS (NASH) PROGRESSION
    Xie, Linglin
    HEPATOLOGY, 2021, 74 : 1079A - 1080A
  • [38] Interference with b-lymphocyte cytokines ameliorates the progression of nonalcoholic steatohepatitis (NASH)
    Sutti, S.
    Bruzzi, S.
    Giudici, G.
    Bozzola, C.
    Albano, E.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S606 - S606
  • [39] Definition and management of nonalcoholic steatohepatitis (NASH)
    Hütteroth, TH
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 : S64 - S67
  • [40] Nonalcoholic steatohepatitis (NASH) drugs market
    Cassidy, Sorcha
    Syed, Basharut A.
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (11) : 745 - 746
12345